Excess pressure integral (XSPI) derived from reservoir-excess pressure analysis is proposed as a novel indicator of cardiovascular dysfunction in hypertensives. Our study investigated the prognostic value of XSPI for stable heart failure (HF) patients.
Heart failure (HF) is a significant public health problem affecting millions of patients worldwide. [1] [2] [3] The incidence of HF increases with age, and prognosis is dismal following the development of HF. 4 Vascular stiffening has been regarded as a contributor to the progression of atherosclerosis, exaggeration of pulsatile hemodynamics, deterioration of ventricular function, worsening buffering function of elastic arteries, suboptimal interaction between the failed left ventricle (LV) and arterial system, and the resultant development of HF symptoms. [5] [6] [7] [8] [9] [10] Pulsatile hemodynamics may be involved in the pathogenesis of acute HF syndrome and predict short-and long-term outcomes in patients hospitalized with HF. 11, 12 Tyberg et al. recently proposed the reservoir-excess pressure approach. 13 This reservoir-excess pressure model separates the measured arterial pressure into reservoir and excess pressure components. 14 Reservoir pressure calculated from central blood pressure waveforms correlated with reflected pressure and predicted cardiovascular events in high-risk patients. 15 Moreover, excess pressure integral (XSPI) derived from the reservoir-excess pressure analysis has been proposed as a novel indicator of cardiovascular dysfunction for predicting cardiovascular events in treated hypertensive individuals because it represents unnecessary work exerted by the ventricle in each cardiac cycle. 16 However, to the best of our knowledge, the predictive ability of the XSPI in HF patients has not been reported. Therefore, we hypothesized that XSPI is a useful prognostic factor for patients with HF. As such, the purpose of our study was to investigate the prognostic significance of the XSPI for predicting the outcome of stable HF patients.
METHODS

Study population
There were 3 groups of subjects in the present study. The main patient group included 64 stable HF patients with echocardiographic evidence of left ventricular systolic dysfunction (SHF), 104 patients with HF with isolated diastolic dysfunction (DHF), and 70 apparently healthy subjects with normal LV function.
Echocardiographic examination was conducted using a multifrequency transducer incorporated in an Artida Echocardiograph (Toshiba Medical Systems Corporation, Tokyo, Japan) according to the recommendations of the American Society of Echocardiography. 17 The following dimensions were measured online from the 2D-guided M-mode echocardiography: LV internal dimension at endsystole and end-diastole, left atrium dimension, aortic root diameter, and interventricular septum and LV posterior wall thickness. LV ejection fraction (EF) and LV mass were calculated from the M-mode measurements. LV end-diastolic volume index (LVEDVI) was LV end-diastolic volume divided by body surface area. 18 We also sampled the mitral inflow profiles, including the ratio of early to late diastolic transmitral velocity (E/A) and the deceleration time of the early velocity wave between the tips of the anterior and posterior mitral leaflets, and the motion of the mitral annulus in the apical 4-chamber view by tissue Doppler technique. 19 The major negative myocardial velocity with the movement of the annulus toward the base of the heart during the early phase of diastole velocity was recorded (E′). Patients with a LVEF of <50% were considered to have SHF. 20 DHF was defined as a LVEF >50% plus the following characteristics: (i) LVEDVI < 97 ml/m 2 and E/E′ >15; or (ii) LVEDVI <97 ml/m 2 , 15 >E/E′ >8, and abnormal LV filling (E/A <0.5, deceleration time >280 ms). 21 Patients with LV dysfunction were enrolled consecutively for the study between May 2002 and December 2005, and the normal controls were selected from previous studies. 18, 22 Our healthy controls were included randomly from several previous clinical studies. 11, 18 Given the marked age differences between normal controls and HF subjects, we adjusted the age and gender through the analysis of covariance test and Cox proportional hazards models and rather than by matching. All study subjects underwent a 2-hour comprehensive noninvasive cardiovascular evaluation, including echocardiography, carotid artery pressure waveform recording by arterial tonometry, and symptoms and signs of HF according to the Framingham criteria. 23 Except for the healthy controls, all subjects were HF patients who had ever been admitted due to dyspnea and consented to receive comprehensive hemodynamic examinations after their symptoms and signs were stabilized. All subjects were prospectively enrolled from several research projects (please see acknowledgement section) consecutively conducted to investigate the hemodynamic mechanisms of HF. None of the subjects had atrial fibrillation or bundle branch block detected by electrocardiography or significant aortic valve disease by echocardiography. All study protocols were approved by our hospital's institutional review board and all subjects gave informed consent before entering into this study.
We determined heart rate from the surface electrocardiogram and measured the systolic blood pressure and diastolic blood pressure under supine resting condition in a quiet, temperature-controlled room with an electronic oscillometric sphygmomanometer. The details were mentioned in the previous study. 11 Blood samples were collected immediately after the comprehensive hemodynamic examination following an overnight fast. Then, estimated glomerular filtration rate (eGFR) was calculated using the modified estimation equation for Chinese patients. 24 N-terminal pro-B-type natriuretic peptide (NT-proBNP) was measured using a commercially available assay (Roche Diagnostics, Basel, Switzerland).
Carotid pressure waveform analysis
Carotid pressure waveforms were registered noninvasively with a tonometer 25 and calibrated with brachial mean BP and DBP to obtain the carotid BP. 26 Reservoir-excess pressure analysis is a time-domain analysis, based on the understanding that the arterial system not only functions as a conduit system, conducting waves to the periphery, but also as a hydraulic integrator, by which the arterial system charges during systole as inflow exceeding outflow, and discharges during diastole, through recoiling of the elastic arteries, continuously supplying blood to vital organs, notably the brain, heart, and kidney. 13 In reservoir-excess pressure analysis, central arterial pressure is presumed to be the instantaneous sum of a pressure associated with aortic blood volume and compliance, and a pressure due to propagation characteristics. 13 Details of the calculations based on the reservoir-excess pressure theory are given in the supplementary file. In brief, XSPI was calculated by subtracting the reservoir pressure from the measured pressure waveform. The systolic and diastolic rate constants represent the time constants relating to the speed of upstroke and downstroke of the carotid arterial pressure waveforms and were derived by using mono-exponential functions to fit the pressure curve. Peak reservoir pressure indicates the highest pressure on the reservoir pressure and integral of reservoir pressure is the area under curve between the reservoir-excess pressure and diastolic blood pressure ( Figure 1 ). Central pulse pressure was calculated as the difference between central systolic blood pressure and central diastolic blood pressure. Augmented pressure was calculated from the central BP waveform as the pressure difference between the first (P1) and second (P2) systolic peaks and expressed as a percentage value of the CPP to define the central augmentation index. All waveform analysis was conducted using custom-written program in Matlab 7.01. (Mathworks, Natick, MA).
Follow up
We linked our data to the National Death Registry to identify mortality and the related causes of the study population. The National Death Registry database registers valid information according to the International Classification of Disease, Ninth Revision (ICD-9). The ICD-9 codes for cardiovascular death were 390-459. 27 
Statistical analysis
Normally distributed variables are expressed as mean ± SD, and comparisons between groups were conducted using the Student's t-test. Skewed data are presented as medians and quartiles and the Mann-Whitney U test was implemented to test for associations. The homogeneity of between-group differences in continuous variables was tested using analysis of covariance test adjusting for age and gender. Next, post-hoc comparisons were made using the Tukey-Kramer test. Categorical data are given as absolute number and relative frequencies and compared using chi-squared tests. A Kaplan-Meier accumulated survival analysis was performed to construct survival plots, and a log-rank statistic was used to compare the survival distributions among the 3 study groups. Because the assumption of proportional hazards did hold (Supplementary Table S1 ), we performed the Cox proportional hazards models to calculate the hazard ratios and 95% confidence intervals of XSPI associated with all-cause mortality. Statistical analysis was performed using SPSS v.20.0 (SPSS, Chicago, IL). The proportions of inconsistencies across different subgroups, not explained by chance, were quantified with the Cochran's Q test. All the tests were performed at a 2-tailed α = 0.05 level of significance.
RESULT
The baseline characteristics of the participants are demonstrated in Table 1 . Subjects with DHF and SHF were older and had higher percentages of smoking habits than healthy controls. Peak reservoir pressure and reservoir pressure integral in the DHF were significantly higher than in the SHF. Compared with controls, XSPI in SHF (14.01 ± 5.16 mm Hg•s) and DHF (13.90 ± 5.05 mm Hg•s) were significantly higher (11.01 ± 3.67 mm Hg•s, both P < 0.001).
In total, 56 deaths (24 cardiovascular origin) occurred during a median follow-up of 9.9 years. Subjects with SHF had the highest 10-year mortality rate, followed by DHF and healthy controls. Of the measured hemodynamic parameters (Table 2) , XSPI was the only significant independent predictor of total mortality after adjusting for age and sex (hazard ratio = 1.50 (per SD increment; 95% confidence interval, 1.15 to 1.95; P = 0.003) in all stable HF subjects. The association between XSPI and total mortality was also evident when XSPI was divided into tertiles ( Figure 2 ). As shown in Table 2 , with further adjustments for possible confounding factors, including LVEF, eGFR, and NT-proBNP, smoking, hypertension, and diabetes mellitus, the association between XSPI and total mortality remained significant in model 3 (hazard ratio = 5.42 (1.33-22.1); P = 0.018) and in model 4 (hazard ratio = 3.62 (1.02-12.9); P = 0.047) ( Table 2) . Except for XSPI, none of other hemodynamic parameters could independently predict all-cause mortality in the multivariate models. As for parameters to predict the cardiovascular death, the result was shown in Supplementary Table S2. In the subgroup analysis stratified by different baseline characteristics including age, gender, NT-proBNP, LVEF, and eGFR, a higher XSPI was consistently associated with a greater risk of total mortality (Figure 3) . Moreover, as demonstrated by the X 2 in Supplementary Table S3, age was the most powerful prognostic index in the prediction of all-cause mortality, followed by XSPI, and LVEF.
DISCUSSION
In subjects with stable HF, we have demonstrated that elevated XSPI was associated with the long-term risk of mortality in patients with stable HF. XSPI has been proposed as a novel maker of cardiovascular dysfunction, 16 however, its utility in HF patients has not been investigated previously. The buffering function of elastic arteries could be characterized by the reservoir-excess pressure theory, 13 and XSPI, a parameter derived from the reservoir-excess pressure analysis, may represent the surplus work done by LV. Consequently, the higher XSPI indicates the inefficient pump function of HF patients and/or suboptimal ventriculoarterial coupling status. It was therefore a reasonable finding that a higher XSPI was associated with poor prognosis in stable HF patients.
DHF, or HF with preserved LVEF, is a prevalent clinical problem, which despite its relatively preserved LV systolic function, was associated with a 4-fold mortality risk compared with HF-free status. 28 However, medical management for this patient population is less evidence-based because most clinical trials have yielded negative results. 29 It has been speculated that DHF is a heterogeneous disease entity and consists of several distinct phenotypes. Here, we have demonstrated that subjects with DHF had very different hemodynamic profiles compared with healthy controls and SHF subjects. Of these hemodynamic parameters, XSPI in DHF subjects were higher than in health controls. After adjusting for other important prognostic factors, the baseline XSPI could accurately predict long-term mortality in DHF patients. Data are presented as mean ± SD. Abbreviations: ANCOVA, analysis of covariance; ANOVA, analysis of variance; DBP, diastolic blood pressure; DHF, diastolic heart failure; eGFR, estimated glomerular filtration rate; E/A, the ratio of early to late diastolic transmitral velocity; E/E', the ratio of transmitral to tissue Doppler early phase of diastole velocity; LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; NT-proBNP, N-terminal pro-brain natriuretic peptide; SBP, systolic blood pressure; SHF, systolic heart failure; PP, pulse pressure; PRI, integral of reservoir pressure; XSPI, excess pressure integral. *P < 0.05, **P < 0.01, ***P < 0.001. a P-value comparisons across HF categories are based on chi-square test of homogeneity for categorical variables; p-values for continuous variables are based on ANOVA.
Davies et al. demonstrated that XSPI could predict cardiovascular outcomes in a prospective clinical trial of
b P-Value comparisons across HF categories for continuous variable on ANCOVA, which adjusted age and sex. c If there was significant between-group differences by ANCOVA test adjusting for age and gender, then we use the Tukey-Kramer test to conduct post hoc comparisons. Table 2 . Cox regression analysis of various hemodynamic parameters for predicting all-cause mortality in patients with stable heart failure (n = 168) The HR was expressed per 1 SD increment of each variable. Model 1: adjust sex, and age. Model 2: adjust sex, age, left ventricular ejection fraction, estimated glomerular filtration rate, heart rate, and N-terminal pro-brain natriuretic peptide. Model 3: adjust sex, age, left ventricular ejection fraction, estimated glomerular filtration rate, and N-terminal pro-brain natriuretic peptide, heart rate, smoking, hypertension, diabetes mellitus. Model 4: adjust sex, age, left ventricular ejection fraction, estimated glomerular filtration rate, and N-terminal pro-brain natriuretic peptide, heart rate, diuretics, Renin-angiotensin system blockade, beta-blocker, statins, aldosterone antagonist. Data are presented as standardized HR. Abbreviations: AI, augmentation index; AP, augmentation pressure; bSBP, brachial systolic blood pressure; CI, confidence interval; cSBP, central systolic blood pressure; cPP, central pulse pressure; DBP, diastolic blood pressure; HR, hazard ratio; PRI, integral of reservoir pressure; XSPI indicates excess pressure integral. *P < 0.05; **P < 0.01; ***P < 0.001.
hypertension subjects. 16 High blood pressure is a well-recognized principal precursor of HF and confers a greater risk for the development of HF in hypertensive patients. 30 Increased arterial stiffness is a direct manifestation of hypertension and vascular aging 31 and is an independent predictor of HF in the elderly and in hypertensives. 32, 33 Therefore, a substantial proportion of hypertensive subjects may have variable degrees of LV dysfunction. Here, XSPI increased with LV dysfunction and the higher XSPI was associated with higher mortality (Figure 2) . Moreover, we have demonstrated that XSPI was significantly related to 10-year all-cause mortality independently of sex, age, LVEF, eGFR, and NT-proBNP. To the best of our knowledge, the present study was the first to demonstrate a significant independent prognostic value of XSPI in patients with stable HF. It should be noted that although the independent prognostic value of XSPI has been demonstrated both in the present study and the ASCOT-CAFE study, 16 the pressure waveforms in these 2 studies were obtained from different sites of arteries. Compared with radial pressure waveforms used in the ASCOT-CAFE study, 16 the carotid pressure waveforms, as exploited in our study, have very dissimilar morphology especially in the upper ascending limb of the waveform. Therefore, even in the same subject, the XSPI obtained from different sites may be very different. Further studies should be conducted to compare the prognostic significance of XSPI derived from different locations of arteries. Climie et al. has shown that XSPI had a significant inverse association with gray matter volume measured by brain magnetic resonance imaging, 34 which provided a link between cardiovascular dysfunction and brain atrophy. Here, elevated XSPI was noted in HF subjects even with preserved LVEF (DHF group), which indicated that XSPI may be a more sensitive maker for the identification of LV dysfunction or impaired ventricular-arterial coupling than LVEF. HF with preserved LVEF occurs in a heterogeneous population, and the independent prognostic role demonstrated in our study suggested that XSPI has incremental value for evaluating, or even differentiating the cardiovascular function phenotypes of HF patients.
Limitations
Several limitations of the present study should be acknowledged. First, being a single-center observational study with subjects identified from previous studies according to the inclusion and exclusion criteria of the present study, there is an inherent selection bias. Second, although a significant association between all-cause mortality and XSPI was demonstrated in our study, with the limited sample size and few events of cardiovascular death, no firm conclusion can be drawn on the association between XSPI and cardiovascular events. A cohort study with a large sample size should be conducted in the future.
In summary, in patients with stable HF, XSPI, a novel maker of cardiovascular dysfunction, was associated with the long-term risk of total mortality.
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